Annual Total Debt:
$602.71M-$493.04M(-45.00%)Summary
- As of today (July 1, 2025), BMRN annual total debt is $602.71 million, with the most recent change of -$493.04 million (-45.00%) on December 31, 2024.
- During the last 3 years, BMRN annual total debt has fallen by -$486.83 million (-44.68%).
- BMRN annual total debt is now -48.68% below its all-time high of $1.17 billion, reached on December 31, 2017.
Performance
BMRN Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$601.96M-$753.00K(-0.12%)Summary
- As of today (July 1, 2025), BMRN quarterly total debt is $601.96 million, with the most recent change of -$753.00 thousand (-0.12%) on March 31, 2025.
- Over the past year, BMRN quarterly total debt has dropped by -$494.58 million (-45.10%).
- BMRN quarterly total debt is now -58.75% below its all-time high of $1.46 billion, reached on September 30, 2020.
Performance
BMRN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
BMRN Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -45.0% | -45.1% |
3 y3 years | -44.7% | -44.8% |
5 y5 years | -29.8% | -30.3% |
BMRN Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -45.0% | at low | -45.3% | at low |
5 y | 5-year | -45.0% | at low | -58.8% | at low |
alltime | all time | -48.7% | >+9999.0% | -58.8% | >+9999.0% |
BMRN Total debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $601.96M(-0.1%) |
Dec 2024 | $602.71M(-45.0%) | $602.71M(+0.0%) |
Sep 2024 | - | $602.69M(-45.2%) |
Jun 2024 | - | $1.10B(+0.3%) |
Mar 2024 | - | $1.10B(+0.1%) |
Dec 2023 | $1.10B(+0.2%) | $1.10B(+0.0%) |
Sep 2023 | - | $1.10B(+0.2%) |
Jun 2023 | - | $1.09B(+0.0%) |
Mar 2023 | - | $1.09B(-0.0%) |
Dec 2022 | $1.09B(+0.4%) | $1.09B(+0.2%) |
Sep 2022 | - | $1.09B(-0.0%) |
Jun 2022 | - | $1.09B(+0.1%) |
Mar 2022 | - | $1.09B(+0.1%) |
Dec 2021 | $1.09B(+0.2%) | $1.09B(+0.2%) |
Sep 2021 | - | $1.09B(-0.0%) |
Jun 2021 | - | $1.09B(+0.1%) |
Mar 2021 | - | $1.09B(+0.0%) |
Dec 2020 | $1.09B(+26.6%) | $1.09B(-25.5%) |
Sep 2020 | - | $1.46B(+0.3%) |
Jun 2020 | - | $1.45B(+68.5%) |
Mar 2020 | - | $863.08M(+0.5%) |
Dec 2019 | $858.82M(+3.4%) | $858.82M(+0.6%) |
Sep 2019 | - | $853.84M(+0.5%) |
Jun 2019 | - | $849.33M(+0.6%) |
Mar 2019 | - | $843.98M(+1.6%) |
Dec 2018 | $830.42M(-29.3%) | $830.42M(-30.8%) |
Sep 2018 | - | $1.20B(+0.7%) |
Jun 2018 | - | $1.19B(+0.7%) |
Mar 2018 | - | $1.18B(+0.7%) |
Dec 2017 | $1.17B(+71.9%) | $1.17B(+0.7%) |
Sep 2017 | - | $1.17B(+72.4%) |
Jun 2017 | - | $676.21M(-2.1%) |
Mar 2017 | - | $690.93M(+1.1%) |
Dec 2016 | $683.24M(+3.2%) | $683.24M(+1.1%) |
Sep 2016 | - | $675.64M(+0.8%) |
Jun 2016 | - | $670.11M(+0.3%) |
Mar 2016 | - | $668.01M(+0.9%) |
Dec 2015 | $662.29M(+3.0%) | $662.29M(-0.8%) |
Sep 2015 | - | $667.79M(+1.0%) |
Jun 2015 | - | $661.49M(+0.9%) |
Mar 2015 | - | $655.49M(+2.0%) |
Dec 2014 | $642.90M(-1.9%) | $642.90M(-2.1%) |
Sep 2014 | - | $656.88M(+0.9%) |
Jun 2014 | - | $650.87M(-1.6%) |
Mar 2014 | - | $661.42M(+0.9%) |
Dec 2013 | $655.57M(+88.3%) | $655.57M(+737.1%) |
Sep 2013 | - | $78.31M(-28.7%) |
Jun 2013 | - | $109.82M(-0.0%) |
Mar 2013 | - | $109.85M(-68.5%) |
Dec 2012 | $348.22M(-0.0%) | $348.22M(-0.0%) |
Sep 2012 | - | $348.30M(-0.0%) |
Jun 2012 | - | $348.31M(-0.0%) |
Mar 2012 | - | $348.33M(-0.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $348.33M(-7.7%) | $348.33M(-0.0%) |
Sep 2011 | - | $348.34M(-7.7%) |
Jun 2011 | - | $377.52M(-0.0%) |
Mar 2011 | - | $377.52M(0.0%) |
Dec 2010 | $377.52M(-24.1%) | $377.52M(-29.2%) |
Sep 2010 | - | $533.41M(+2.3%) |
Jun 2010 | - | $521.24M(-0.7%) |
Mar 2010 | - | $524.86M(+5.6%) |
Dec 2009 | $497.08M(-12.5%) | $497.08M(0.0%) |
Sep 2009 | - | $497.08M(0.0%) |
Jun 2009 | - | $497.08M(-12.4%) |
Mar 2009 | - | $567.40M(-0.1%) |
Dec 2008 | $567.82M(+14.2%) | $567.82M(+14.2%) |
Sep 2008 | - | $497.24M(-1.2%) |
Jun 2008 | - | $503.06M(-0.1%) |
Mar 2008 | - | $503.37M(+1.2%) |
Dec 2007 | $497.38M(+115.6%) | $497.38M(-12.9%) |
Sep 2007 | - | $570.87M(-0.1%) |
Jun 2007 | - | $571.49M(+131.2%) |
Mar 2007 | - | $247.23M(+7.2%) |
Dec 2006 | $230.73M(+2.9%) | $230.73M(-23.1%) |
Sep 2006 | - | $299.87M(-19.8%) |
Jun 2006 | - | $374.02M(-5.3%) |
Mar 2006 | - | $394.88M(+76.1%) |
Dec 2005 | $224.26M(-17.2%) | $224.26M(-0.8%) |
Sep 2005 | - | $226.14M(-0.9%) |
Jun 2005 | - | $228.11M(+34.5%) |
Mar 2005 | - | $169.66M(-37.4%) |
Dec 2004 | $270.84M(+116.7%) | $270.84M(+0.0%) |
Sep 2004 | - | $270.81M(+44.8%) |
Jun 2004 | - | $187.01M(+49.6%) |
Mar 2004 | - | $125.00M(0.0%) |
Dec 2003 | $125.00M(>+9900.0%) | $125.00M(0.0%) |
Sep 2003 | - | $125.00M(0.0%) |
Jun 2003 | - | $125.00M(>+9900.0%) |
Mar 2003 | - | $0.00(0.0%) |
Dec 2002 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2002 | - | $2.91M(>+9900.0%) |
Jun 2002 | - | $0.00(-100.0%) |
Mar 2002 | - | $5.22M(-6.0%) |
Dec 2001 | $5.55M(+6589.2%) | $5.55M(+2203.7%) |
Sep 2001 | - | $241.00K(-18.6%) |
Jun 2001 | - | $296.00K(+289.5%) |
Mar 2001 | - | $76.00K(-8.4%) |
Dec 2000 | $83.00K(-25.2%) | $83.00K(-8.8%) |
Sep 2000 | - | $91.00K(-6.2%) |
Jun 2000 | - | $97.00K(-5.8%) |
Mar 2000 | - | $103.00K(-7.2%) |
Dec 1999 | $111.00K(+11.0%) | $111.00K(+11.0%) |
Sep 1999 | - | $100.00K(-99.6%) |
Jun 1999 | - | $26.10M(>+9900.0%) |
Mar 1999 | - | $100.00K |
Dec 1998 | $100.00K | - |
FAQ
- What is BioMarin Pharmaceutical annual total debt?
- What is the all time high annual total debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual total debt year-on-year change?
- What is BioMarin Pharmaceutical quarterly total debt?
- What is the all time high quarterly total debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly total debt year-on-year change?
What is BioMarin Pharmaceutical annual total debt?
The current annual total debt of BMRN is $602.71M
What is the all time high annual total debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total debt is $1.17B
What is BioMarin Pharmaceutical annual total debt year-on-year change?
Over the past year, BMRN annual total debt has changed by -$493.04M (-45.00%)
What is BioMarin Pharmaceutical quarterly total debt?
The current quarterly total debt of BMRN is $601.96M
What is the all time high quarterly total debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total debt is $1.46B
What is BioMarin Pharmaceutical quarterly total debt year-on-year change?
Over the past year, BMRN quarterly total debt has changed by -$494.58M (-45.10%)